Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Manifestations of Eosinophilic Esophagitis in Children and Adolescents: A Single-Center, Matched Case-Control Study

  • Roh, Ji Hyeon (Department of Pediatrics, Gachon University Gil Medical Center) ;
  • Ryoo, Eell (Department of Pediatrics, Gachon University Gil Medical Center) ;
  • Tchah, Hann (Department of Pediatrics, Gachon University Gil Medical Center)
  • Received : 2019.08.15
  • Accepted : 2019.11.30
  • Published : 2020.07.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: To examine the prevalence and clinical manifestations of eosinophilic esophagitis (EoE) in Korea children. Methods: The study was designed as a 1:2 matching case-control study. Using information from the endoscopic database of a tertiary center, we retrospectively reviewed the medical records of patients aged 18 years or younger who underwent upper gastrointestinal endoscopy between January 2014 and December 2017. A total of 21 patients were diagnosed with EoE based on current diagnostic criteria. In addition, 42 controls with normal esophageal biopsy findings matched to each EoE case by sex, age (±1 months), and season were randomly selected during the study period. Results: The mean age of EoE diagnosis was 12.1±4.0 years and the male-to-female ratio was 2:1. The proportion of allergic diseases in patients with EoE (28.6%) was higher than that in the controls (6.8%) (p=0.04). Most EoE patients tested for allergy were positive for at least one antigen, which was significantly different to the controls (88.2% vs. 47.4%, p=0.01). Characteristic endoscopic findings of EoE were noted in 19 patients (90.5%), but 2 patients (9.5%) showed normal esophageal mucosa. The clinical symptoms of EoE were improved by a proton-pump inhibitor in 10 patients (50.0%), and by an H2 blocker in 9 patients (45.0%). Only one patient (5.0%) required inhaled steroids. Conclusion: While EoE is rare in the Korean pediatric population, the results of this study will improve our understanding of the clinical manifestations of the disease.

Keywords

References

  1. Landres RT, Kuster GG, Strum WB. Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology 1978;74:1298-301. https://doi.org/10.1016/0016-5085(78)90710-2
  2. Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 1993;38:109-16. https://doi.org/10.1007/BF01296781
  3. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007;133:1342-63. https://doi.org/10.1053/j.gastro.2007.08.017
  4. Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference. Gastroenterology 2018;155:1022-33.e10. https://doi.org/10.1053/j.gastro.2018.07.009
  5. Spergel JM, Brown-Whitehorn TF, Beausoleil JL, Franciosi J, Shuker M, Verma R, et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr 2009;48:30-6. https://doi.org/10.1097/MPG.0b013e3181788282
  6. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011;128:3-20.e6; quiz 21-2. https://doi.org/10.1016/j.jaci.2011.02.040
  7. Navarro P, Arias A, Arias-Gonzalez L, Laserna-Mendieta EJ, Ruiz-Ponce M, Lucendo AJ. Systematic review with meta-analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther 2019;49:1116-25. https://doi.org/10.1111/apt.15231
  8. Joo MK, Park JJ, Kim SH, Kim KH, Jung W, Yun JW, et al. Prevalence and endoscopic features of eosinophilic esophagitis in patients with esophageal or upper gastrointestinal symptoms. J Dig Dis 2012;13:296-303. https://doi.org/10.1111/j.1751-2980.2012.00589.x
  9. Jensen ET, Kappelman MD, Kim HP, Ringel-Kulka T, Dellon ES. Early life exposures as risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2013;57:67-71. https://doi.org/10.1097/MPG.0b013e318290d15a
  10. Dellon ES. Epidemiology of eosinophilic esophagitis. Gastroenterol Clin North Am 2014;43:201-18. https://doi.org/10.1016/j.gtc.2014.02.002
  11. Furuta GT, Katzka DA. Eosinophilic esophagitis. N Engl J Med 2015;373:1640-8. https://doi.org/10.1056/NEJMra1502863
  12. Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol 2003;112:796-7. https://doi.org/10.1016/S0091-6749(03)01715-9
  13. Rayapudi M, Mavi P, Zhu X, Pandey AK, Abonia JP, Rothenberg ME, et al. Indoor insect allergens are potent inducers of experimental eosinophilic esophagitis in mice. J Leukoc Biol 2010;88:337-46. https://doi.org/10.1189/jlb.0110025
  14. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 2001;107:83-90. https://doi.org/10.1172/JCI10224
  15. Lucendo AJ, Arias A, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016;14:13-22.e1. https://doi.org/10.1016/j.cgh.2015.07.041
  16. Gutierrez-Junquera C, Fernandez-Fernandez S, Cilleruelo ML, Rayo A, Echeverria L, Quevedo S, et al. High prevalence of response to proton-pump inhibitor treatment in children with esophageal eosinophilia. J Pediatr Gastroenterol Nutr 2016;62:704-10. https://doi.org/10.1097/MPG.0000000000001019
  17. Orel R, Erzen J, Dolenc Strazar Z. Development of urinary incontinence in a 7-year old boy after therapy with proton pump inhibitors and complete resolution of his clinicopathologic features of eosinophilic esophagitis after H2-receptor antagonist treatment: a case report. Zdrav Vestn 2017;86:199-206.
  18. Ishimura N, Ishihara S, Kinoshita Y. Sustained acid suppression by potassium-competitive acid blocker (P-CAB) may be an attractive treatment candidate for patients with eosinophilic esophagitis. Am J Gastroenterol 2016;111:1203-4. https://doi.org/10.1038/ajg.2016.167
  19. Soon IS, Butzner JD, Kaplan GG, deBruyn JC. Incidence and prevalence of eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr 2013;57:72-80. https://doi.org/10.1097/MPG.0b013e318291fee2
  20. Robson J, O'Gorman M, McClain A, Mutyala K, Davis C, Barbagelata C, et al. Incidence and prevalence of pediatric eosinophilic esophagitis in Utah based on a 5-year population-based study. Clin Gastroenterol Hepatol 2019;17:107-14.e1. https://doi.org/10.1016/j.cgh.2018.06.028
  21. Incheon Metropolitan City. Resident registration population statistical table of 2017. Available from: https://www.incheon.go.kr/data/DATA010001#none
  22. Kapel RC, Miller JK, Torres C, Aksoy S, Lash R, Katzka DA. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology 2008;134:1316-21. https://doi.org/10.1053/j.gastro.2008.02.016
  23. Sherrill JD, Gao PS, Stucke EM, Blanchard C, Collins MH, Putnam PE, et al. Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol 2010;126:160-5.e3. https://doi.org/10.1016/j.jaci.2010.04.037
  24. Homan M, Blagus R, Jeverica AK, Orel R. Pediatric eosinophilic esophagitis in Slovenia: data from a retrospective 2005-2012 epidemiological study. J Pediatr Gastroenterol Nutr 2015;61:313-8. https://doi.org/10.1097/MPG.0000000000000797
  25. Almansa C, Krishna M, Buchner AM, Ghabril MS, Talley N, DeVault KR, et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol 2009;104:828-33. https://doi.org/10.1038/ajg.2008.169
  26. Eroglu Y, Lu H, Terry A, Tendler J, Knopes B, Corless C, et al. Pediatric eosinophilic esophagitis: single-center experience in northwestern USA. Pediatr Int 2009;51:612-6. https://doi.org/10.1111/j.1442-200X.2008.02796.x
  27. Kim HP, Vance RB, Shaheen NJ, Dellon ES. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:988-96.e5. https://doi.org/10.1016/j.cgh.2012.04.019
  28. Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol 2006;18:211-7. https://doi.org/10.1097/00042737-200602000-00015
  29. Kim GH, Jung KW, Jung HY, Choi KD, Lee J, Park YS, et al. Diagnostic trends and clinical characteristics of eosinophilic esophagitis: a Korean, single-center database Study. J Neurogastroenterol Motil 2018;24:248-54. https://doi.org/10.5056/jnm17047
  30. Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 2007;102:1301-6. https://doi.org/10.1111/j.1572-0241.2007.01179.x
  31. Molina-Infante J, van Rhijn BD. Interactions between gastro-oesophageal reflux disease and eosinophilic oesophagitis. Best Pract Res Clin Gastroenterol 2015;29:749-58. https://doi.org/10.1016/j.bpg.2015.06.009